|
1 |
β2-Agonists and Physical Performance
Enthalten in Sports medicine Bd. 41, 25.11.2012, Nr. 1, date:1.2011: 39-57
|
|
|
|
2 |
2010 Position Paper of the Italian Society of Hypertension (SIIA)
Enthalten in High blood pressure & cardiovascular prevention Bd. 18, 27.11.2012, Nr. 1, date:3.2011: 37-40
|
|
|
|
3 |
5% Lidocaine Medicated Plaster in Elderly Patients with Postherpetic Neuralgia
Enthalten in Drugs & aging Bd. 28, 31.8.2012, Nr. 9, date:9.2011: 693-702
|
|
|
|
4 |
69th Annual Meeting of the American Academy of Dermatology
Enthalten in American journal of clinical dermatology Bd. 12, 10.9.2012, Nr. 3, date:6.2011: 215-216
|
|
|
|
5 |
A Cohort Study Exploring Determinants of Safety-Related Regulatory Actions for Biopharmaceuticals
Enthalten in Drug safety Bd. 35, 13.12.2012, Nr. 5, date:5.2012: 417-427
|
|
|
|
6 |
A Comprehensive Review of Rapid-Onset Opioids for Breakthrough Pain
Enthalten in CNS drugs Bd. 26, 13.12.2012, Nr. 6, date:6.2012: 509-535
|
|
|
|
7 |
A Cost-Consequence Analysis of Pregabalin versus Usual Care in the Symptomatic Treatment of Refractory Low Back Pain
Enthalten in Clinical drug investigation Bd. 30, 29.8.2012, Nr. 8, date:8.2010: 517-531
|
|
|
|
8 |
A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five European countries
Enthalten in Applied health economics and health policy Bd. 10, 6.8.2012, Nr. 2, date:3.2012: 127-138
|
|
|
|
9 |
A Current Review of Juvenile Pemphigus Vulgaris
Enthalten in American journal of clinical dermatology Bd. 11, 10.9.2012, Nr. 1, date:2.2010: 21-33
|
|
|
|
10 |
A Decade of Safety-Related Regulatory Action in the Netherlands
Enthalten in Drug safety Bd. 33, 21.11.2012, Nr. 6, date:6.2010: 463-474
|
|
Administration
